Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: The LateTIME randomized trial

Jay H. Traverse, Timothy D. Henry, Stephen G. Ellis, Carl J. Pepine, James T. Willerson, David X M Zhao, John R. Forder, Barry J. Byrne, Antonis K. Hatzopoulos, Marc S. Penn, Emerson C. Perin, Kenneth W. Baran, Jeffrey Chambers, Charles Lambert, Ganesh Raveendran, Daniel I. Simon, Douglas E. Vaughan, Lara M. Simpson, Adrian P. Gee, Doris A. TaylorChristopher R. Cogle, James D. Thomas, Guilherme V. Silva, Beth C. Jorgenson, Rachel E. Olson, Sherry Bowman, Judy Francescon, Carrie Geither, Eileen Handberg, Deirdre X. Smith, Sarah Baraniuk, Linda B. Piller, Catalin Loghin, David Aguilar, Sara Richman, Claudia Zierold, Judy Bettencourt, Shelly L. Sayre, Rachel W. Vojvodic, Sonia I. Skarlatos, David J. Gordon, Ray F. Ebert, Minjung Kwak, Lemuel A. Moyé, Robert D. Simari

Research output: Contribution to journal › Article › peer-review

352 Scopus citations

Fingerprint

Dive into the research topics of 'Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: The LateTIME randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences